261 related articles for article (PubMed ID: 28419517)
41. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--performance in formaldehyde-fixed tissue and application in clinical problem cases.
Miettinen M; Lasota J
Pathol Res Pract; 1997; 193(1):9-19. PubMed ID: 9112269
[TBL] [Abstract][Full Text] [Related]
42. The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction.
Summers KE; Davies AJ; Matthews J; Jenner MJ; Cornelius V; Amess JA; Norton AJ; Rohatiner AZ; Fitzgibbon J; Lister TA; Goff LK
Br J Haematol; 2002 Aug; 118(2):563-6. PubMed ID: 12139746
[TBL] [Abstract][Full Text] [Related]
43. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
[TBL] [Abstract][Full Text] [Related]
44. [Detection of t (14; 18) chromosomal translocation in paraffin-embedded tissues of follicular lymphoma and its clinical significance].
Zhang PH; Zhou XY; Shui RH; Zhang TM; Zheng AH; Guo XH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):600-4. PubMed ID: 18070448
[TBL] [Abstract][Full Text] [Related]
45. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
[TBL] [Abstract][Full Text] [Related]
46. Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Galimberti S; Luminari S; Ciabatti E; Grassi S; Guerrini F; Dondi A; Marcheselli L; Ladetto M; Piccaluga PP; Gazzola A; Mannu C; Monitillo L; Mantoan B; Del Giudice I; Della Starza I; Cavalli M; Arcaini L; Tucci A; Palumbo GA; Rigacci L; Pulsoni A; Vitolo U; Boccomini C; Vallisa D; Bertoldero G; Gaidano G; Musto P; Petrini M; Federico M
Clin Cancer Res; 2014 Dec; 20(24):6398-405. PubMed ID: 25316810
[TBL] [Abstract][Full Text] [Related]
47. [Detection and application of bcl-2/IgH gene translocation and immunoglobulin gene rearrangement in follicular lymphoma].
Xu J; Yan LX; Zhang KP; Cui Q; Chen J; Zhu XL; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):423-426. PubMed ID: 29886585
[No Abstract] [Full Text] [Related]
48. JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements.
Jenner MJ; Summers KE; Norton AJ; Amess JA; Arch RS; Young BD; Lister TA; Fitzgibbon J; Goff LK
Br J Haematol; 2002 Aug; 118(2):550-8. PubMed ID: 12139744
[TBL] [Abstract][Full Text] [Related]
49. Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients.
Colleoni GW; Duarte LC; Kerbauy FR; Noguti MA; Felix RS; De Oliveira JS; Figueiredo MS; Alves AC
Leuk Lymphoma; 2004 Mar; 45(3):539-45. PubMed ID: 15160916
[TBL] [Abstract][Full Text] [Related]
50. Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
Della Starza I; De Novi LA; Santoro A; Salemi D; Spinelli O; Tosi M; Soscia R; Paoloni F; Cappelli LV; Cavalli M; Apicella V; Bellomarino V; Di Lello E; Vitale A; Vignetti M; Fabbiano F; Rambaldi A; Bassan R; Guarini A; Chiaretti S; Foà R
J Mol Diagn; 2022 Aug; 24(8):893-900. PubMed ID: 35710027
[TBL] [Abstract][Full Text] [Related]
51. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
[TBL] [Abstract][Full Text] [Related]
52. BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
van Oers MH; Tönnissen E; Van Glabbeke M; Giurgea L; Jansen JH; Klasa R; Marcus RE; Wolf M; Kimby E; Vranovsky A; Holte H; Hagenbeek A; van der Reijden BA
J Clin Oncol; 2010 May; 28(13):2246-52. PubMed ID: 20368567
[TBL] [Abstract][Full Text] [Related]
53. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
54. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.
Summers KE; Goff LK; Wilson AG; Gupta RK; Lister TA; Fitzgibbon J
J Clin Oncol; 2001 Jan; 19(2):420-4. PubMed ID: 11208834
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.
Tysarowski A; Fabisiewicz A; Paszkiewicz-Kozik E; Kulik J; Walewski J; Siedlecki JA
Acta Biochim Pol; 2007; 54(1):135-42. PubMed ID: 17351675
[TBL] [Abstract][Full Text] [Related]
56. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
[TBL] [Abstract][Full Text] [Related]
57. Gene rearrangements in follicular lymphoma among Indonesian.
Oehadian A; Koide N; Fianza PI; Fadjari TH; Sumantri R; Supandiman I; Yokochi T
Acta Med Indones; 2006; 38(2):72-6. PubMed ID: 16799206
[TBL] [Abstract][Full Text] [Related]
58. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
Buchonnet G; Jardin F; Jean N; Bertrand P; Parmentier F; Tison S; Lepretre S; Contentin N; Lenain P; Stamatoullas-Bastard A; Tilly H; Bastard C
Leukemia; 2002 Sep; 16(9):1852-6. PubMed ID: 12200703
[TBL] [Abstract][Full Text] [Related]
59. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
[TBL] [Abstract][Full Text] [Related]
60. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
